Janssen Pharmaceuticals

Rediff.com » News » Janssen Pharmaceuticals

News for Janssen Pharmaceuticals

News
Business

AstraZeneca reaffirms Covid vaccine safety amid rare TTS concerns

In light of recent concerns surrounding potential rare side effects of the AstraZeneca-Oxford COVID-19 vaccine, the pharmaceutical giant has reiterated its commitment to patient safety while......

AstraZeneca's COVID-19 Vaccine: The TTS Factor

'It is admitted that the AZ vaccine can, in very rare cases, cause TTS.' IMAGE: A vial labelled 'AstraZeneca COVID-19 Vaccine'. Photograph: Illustration/Dado Ruvic/Reuters The controversial......

Johnson & Johnson pauses Covid vaccine trial as participant falls ill

Pharma major Johnson & Johnson has said its COVID-19 vaccine study has been temporarily halted due to an unexplained illness in a trial participant. "We have temporarily paused further dosing in......

Big Pharma cures for ailing heritage monuments

The world of big pharma and that of cultural heritage protection do not obviously overlap. But in fact there are logical connections, or so claims Dr Alex Valcke, vice president of one of the......

Ranbaxy signs Canadian generic deal

Ranbaxy Laboratories, the country's largest pharmaceutical company by sales, on Wednesdayannounced that it had signed a licensing and supply agreement that will make it the first Indian company to......

Janssen Pharmaceuticals

News for Janssen Pharmaceuticals

AstraZeneca reaffirms Covid vaccine safety amid rare TTS concerns

AstraZeneca's COVID-19 Vaccine: The TTS Factor

Johnson & Johnson pauses Covid vaccine trial as participant falls ill

Big Pharma cures for ailing heritage monuments

Ranbaxy signs Canadian generic deal

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS